A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID vaccine strategies. Study: ...
The Johns Hopkins CIR is looking for healthy volunteers between 18 and 64 years old for an intranasal Covid vaccine study.
A 4th dose of the bivalent or monovalent Omicron BA.1-adapted BNT162b2 vaccine elicits robust neutralizing responses in adults aged 18 to 55.
WASHINGTON -- The surgeon general is warning Americans about the "urgent threat of health misinformation" amid the government's current push to boost stalling vaccination rates. Dr. Vivek Murthy's ...
A fourth dose of an mRNA COVID-19 vaccine could increase antibodies and provide more protection from the virus, according to a new study from Israel. Researchers released new preliminary data Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results